title: Calcium-independent inhibition of glucose transport in PC-12 and L6 cells by calcium channel antagonists.
abstract: The goal of these studies was to determine whether different calcium channel antagonists affect glucose transport in a neuronal cell line. Rat pheochromocytoma (PC-12) cells were treated with L-, T-, and N-type calcium channel antagonists before measurement of accumulation of 2-[(3)H]deoxyglucose (2-[(3)H]DG). The L-type channel antagonists nimodipine, nifedipine, verapamil, and diltiazem all inhibited glucose transport in a dose-dependent manner (2-150 microM) with nimodipine being the most potent and diltiazem only moderately inhibiting transport. T- and N-type channel antagonists had no effect on transport. The L-type channel agonist l-BAY K 8644 also inhibited uptake of 2-[(3)H]DG. The ability of these drugs to inhibit glucose transport was significantly diminished by the presence of unlabeled 2-DG in the uptake medium. Some experiments were performed in the presence of EDTA (4 mM) or in uptake buffer without calcium. The absence of calcium in the uptake medium had no effect on inhibition of glucose transport by nimodipine or verapamil. To examine the effects of these drugs on a cell model of a peripheral tissue, we studied rat L6 muscle cells. The drugs inhibited glucose transport in L6 myoblasts in a dose-dependent manner that was independent of calcium in the uptake medium. These studies suggest that the calcium channel antagonists inhibit glucose transport in cells through mechanisms other than the antagonism of calcium channels, perhaps by acting directly on glucose transporters.
authors.affiliation: Department of Pharmacology, Louisiana State University Health Sciences Center, Shreveport, Louisiana 71130, USA.
authors.forename: Timothy D
authors.initials: TD
authors.lastname: Ardizzone
authors.forename: Xiao-Hong
authors.initials: XH
authors.lastname: Lu
authors.forename: Donard S
authors.initials: DS
authors.lastname: Dwyer
mesh_terms: D000818:Animals; D001692:Biological Transport / Q000187:drug effects; D002118:Calcium / Q000502:physiology*; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000737:chemistry / Q000494:pharmacology*; D003847:Deoxyglucose / Q000493:pharmacokinetics; D004305:Dose-Response Relationship, Drug; D009004:Monosaccharide Transport Proteins / Q000037:antagonists & inhibitors*; D009994:Osmolar Concentration; D016716:PC12 Cells; D051381:Rats; D013997:Time Factors
chemical_list: D002121:Calcium Channel Blockers; D009004:Monosaccharide Transport Proteins; D003847:Deoxyglucose; D002118:Calcium